🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
Nivolumab is an anti-PD-1 antibody highly effective in patients with relaps...
Status
Unknown
Location
National Research Center for Hematology
Start Date
2019-08-19
Trial ID
NCT05660993
Treatments Being Tested
This is a Phase 1b/2 randomized study of Iberdomide (CC-220) added to 3 dif...
Status
Withdrawn
Location
Beth Israel Deaconess Medical Center
Start Date
2021-10-10
Trial ID
NCT04882163
Researchers are looking for a way to treat classical Hodgkin lymphoma (cHL)...
Status
Completed
Location
The University of Arizona Cancer Center - North Campus ( Site 2216)
Start Date
2022-10-18
Trial ID
NCT05508867
Treatments Being Tested
The objective of the study is evaluation of efficacy of Bendamustine, Gemcy...
Status
Completed
Location
Oddział Kliniczny Onkologii, Centrum Onkologii im. Prof. F. Łukaszczyka
Start Date
2017-11-06
Trial ID
NCT03615664
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of inotuzumab ozogami...
Status
Terminated
Location
Disney Family Cancer Center at Providence St Joseph Medical Center
Start Date
2011-04-04
Trial ID
NCT01232556
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of bendamustin...
Status
Completed
Location
Emory University
Start Date
2012-02-09
Trial ID
NCT01535924
Treatments Being Tested
This study will treat patients with diffuse large B-cell lymphoma (DLBCL). ...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2025-08-19
Trial ID
NCT07059650
Treatments Being Tested
The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-11-03
Trial ID
NCT04663347
Treatments Being Tested